Transcatheter Aortic Valve Implantation in Nonagenarians: Procedural Outcome and Mid-Term Results

Smita Scholtz*, Zisis Dimitriadis, Marios Vlachojannis, Cornelia Piper, Dieter Horstkotte, Marcus Wiemer, Jan Gummert, Buntaro Fujita, Michael Benzinger, Stephan M. Ensminger, Jochen Börgermann, Werner Scholtz

*Korrespondierende/r Autor/-in für diese Arbeit
4 Zitate (Scopus)


Background: For nonagenarians with symptomatic severe aortic stenosis transcatheter aortic valve implantation (TAVI) has become a feasible therapeutic option. Therefore, the aim of this study was to evaluate the procedural outcomes and mid-term follow-up in this patient group and compare this to octogenarians. Methods: From 1359 patients who underwent TAVI at our institution between March 2009 and February 2016, 82 patients were nonagenarians and 912 were octogenarians. In nonagenarians, mean age was 91.9 ± 1.4 years and compared to octogenarians showed a significantly higher logistic EuroScore (27.7 ± 14.8% vs. 23.1 ± 14.4, p = 0.005) and STS Score (8.5 ± 4.8% vs. 6.3 ± 6.7, p = 0.001). Results: There were no significant differences with regard to stroke rate, pacemaker implantation rate and major vascular complications between the two groups. Thirty-day mortality was 9.8% in nonagenarians and 4.1% in octogenarians (p = 0.04). At 1 year, all-cause mortality increased to 30.9% vs. 18.6% (n.s.). Conclusion: Nonagenarians showed an increased periprocedural mortality during TAVI and higher mortality in follow-up compared to octogenarians. Age alone is not a predictive factor but indication for treatment should be carefully evaluated by the heart team on an individual basis.

ZeitschriftHeart Lung and Circulation
Seiten (von - bis)725-730
PublikationsstatusVeröffentlicht - 06.2018


Untersuchen Sie die Forschungsthemen von „Transcatheter Aortic Valve Implantation in Nonagenarians: Procedural Outcome and Mid-Term Results“. Zusammen bilden sie einen einzigartigen Fingerprint.